By: Jody Lutz
Reading Time: 2 minutes
The Centers for Disease Control and Prevention (CDC) state in its opioid prescribing guidelines fact sheet, that, “when opioids are started, clinicians should prescribe the lowest effective dosage. Clinicians should use caution when prescribing opioids at any dosage, should carefully reassess evidence of individual benefits and risks when considering increasing dosage to ≥50 morphine milligram equivalents (MME)/day, and should avoid increasing dosage to ≥90 MME/day or carefully justify a decision to titrate dosage to ≥90 MME/day.”
It is important to note that the CDC guidelines do not say that physicians cannot prescribe doses above 90 MME. However, justification in the patient’s chart should be provided in detail.
Several states, have adopted rules regarding daily MME amounts. California, has written guidelines that require justification for a daily opioid dosage above 80 MME, other states require consultation, some merely suggest it.
Maine has implemented a 100 MME per day limit on opioid prescriptions (except for terminal cancer and palliative care).
Let’s do the math. Exactly how much is 90 MME:
• 90 mg of hydrocodone (9 tablets of hydrocodone/ acetaminophen 10/325)
• 60 mg of oxycodone (~2 tablets of oxycodone sustained-release 30 mg)
• ~20 mg of methadone (4 tablets of methadone 5 mg)
The CDC has provided guidance for how to calculate MME for commonly prescribed opioids (see table). Calculate the patient’s total daily dose of their current opioid (including “as needed” doses), and multiply by the conversion factor shown in the table. This would be the patient’s MME dose per day.
View Table in HTML
The CDC also has a mobile app available for download featuring a Morphine Milligram Equivalent (MME) calculator, summaries of key recommendations and a link to the full Guidelines. It is available in the Apple Store or via Google Play for Android devices.
Backlash to the 90 MME Policy
The backlash regarding the policy implementation from the medical community has focused on several issues. The calculation utilized to assess the 90 MME marker as an independent calculation not considering unique patient conditions such as age, potential drug-drug interactions, comorbidities, weight, metabolization, and renal/hepatic function. Polypharmacy may increase potential overdose scenarios as well.
Controversy aside...What is the end goal of these policies? Simply, an effort to limit the number of opioid overdose deaths. A number that continues to increase across America, impacting all demographic groups.
Subscribe to the AffirmHealth blog for future updates on the MME discussion as well as other topics of concern for your patients and your practice:
The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.